Author

Arvind Ravi

Broad InstituteORCID 0000-0003-2461-3533Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Research Focus:differential expression· 3 Research Focus:gene regulatory network inference· 3 Approach:statistical model· 3 Assay:bulk RNA-seq· 2 Assay:whole-exome sequencing· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1

Frequent Co-Authors

Gad A. GetziD· 3 shared Chip StewartiD· 2 shared Ignaty LeshchineriD· 2 shared Jaegil KimiD· 2 shared Mark Holton· 2 shared Monica B. ArniellaiD· 2 shared Nir HacoheniD· 2 shared Samuel S. FreemaniD· 2 shared

Activity by Year

2022-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersGenomics

Gad A. GetzORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Cancer Biologynpj Precision OncologyPeer-reviewedSep 26, 2025

Single Cell RNA-sequencing of BCG naive and recurrent non-muscle invasive bladder cancer reveals a CD6/ALCAM mediated immune-suppressive pathway

Ivan Jurić, Emily E. Fink, Hong Qiu…·Byron Lee

This study uses single-cell RNA sequencing to identify a CD6/ALCAM-mediated immune-suppressive pathway in recurrent NMIBC, suggesting CD6 as a potential therapeutic target.

6 citationstop 3%

humanscRNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintOct 22, 2024

Comprehensive structure-function analysis reveals gain- and loss-of-function mechanisms impacting oncogenic KRAS activity

Jason J. Kwon, Julien Dilly, Shengwu Liu…·Andrew J. Aguirre

This study uses deep mutational scanning to analyze KRAS variants, identifying gain- and loss-of-function mechanisms and their impact on oncogenic activity.

13 citations

humanproteomics

𝕏 PostBluesky

GenomicsbioRxivPreprintMar 21, 2022

Integrative Analysis of Checkpoint Blockade Response in Advanced Non-Small Cell Lung Cancer

Arvind Ravi, Justin F. Gainor, Monica B. Arniella…·Matthew David Hellmann

This study identifies molecular and immune features associated with response to anti-PD-(L)1 therapy in NSCLC using a cohort of 393 patients.

1 citation

humanwhole-exome sequencing

𝕏 PostBluesky

GenomicsCell Reports MedicinePeer-reviewedFeb 1, 2022

Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma

Samuel S. Freeman, Moshe Sade-Feldman, Jaegil Kim…·Nir Hacohen

The paper develops DNA- and RNA-based models combining immune and tumor features to predict outcomes of checkpoint inhibition in melanoma.

38 citations

humanwhole-exome sequencing

𝕏 PostBluesky